Global and Japan Wet Age Related Macular Degeneration (AMD) Market Size, Status and Forecast 2020-2026

Global and Japan Wet Age Related Macular Degeneration (AMD) Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Wet Age-Related Macular Degeneration (Wet AMD)
1.2.3 Dry Age-Related Macular Degeneration (Dry AMD)
1.3 Market by Application
1.3.1 Global Wet Age Related Macular Degeneration (AMD) Market Share by Application: 2020 VS 2026
1.3.2 Above 75 Years
1.3.3 Above 60 Years
1.3.4 Above 40 Years
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Wet Age Related Macular Degeneration (AMD) Market Perspective (2015-2026)
2.2 Global Wet Age Related Macular Degeneration (AMD) Growth Trends by Regions
2.2.1 Wet Age Related Macular Degeneration (AMD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Wet Age Related Macular Degeneration (AMD) Historic Market Share by Regions (2015-2020)
2.2.3 Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Market Size
3.1.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue (2015-2020)
3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2015-2020)
3.2 Global Wet Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Wet Age Related Macular Degeneration (AMD) Revenue
3.4 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wet Age Related Macular Degeneration (AMD) Revenue in 2019
3.5 Key Players Wet Age Related Macular Degeneration (AMD) Area Served
3.6 Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Type (2015-2026)
4.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Type (2015-2020)
4.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2021-2026)
5 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Application (2015-2026)
5.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Application (2015-2020)
5.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Wet Age Related Macular Degeneration (AMD) Market Size (2015-2026)
6.2 North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
6.3 North America Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
6.4 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2015-2026)
7.2 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
7.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
7.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Wet Age Related Macular Degeneration (AMD) Market Size (2015-2026)
8.2 China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
8.3 China Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
8.4 China Wet Age Related Macular Degeneration (AMD) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Wet Age Related Macular Degeneration (AMD) Market Size (2015-2026)
9.2 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
9.3 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
9.4 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size (2015-2026)
10.2 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
10.3 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
10.4 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novartis International (Switzerland)
11.1.1 Novartis International (Switzerland) Company Details
11.1.2 Novartis International (Switzerland) Business Overview
11.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction
11.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020))
11.1.5 Novartis International (Switzerland) Recent Development
11.2 Bayer (Germany)
11.2.1 Bayer (Germany) Company Details
11.2.2 Bayer (Germany) Business Overview
11.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Introduction
11.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.2.5 Bayer (Germany) Recent Development
11.3 Acucela (US)
11.3.1 Acucela (US) Company Details
11.3.2 Acucela (US) Business Overview
11.3.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.3.5 Acucela (US) Recent Development
11.4 Neurotech Pharmaceuticals (US)
11.4.1 Neurotech Pharmaceuticals (US) Company Details
11.4.2 Neurotech Pharmaceuticals (US) Business Overview
11.4.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.4.5 Neurotech Pharmaceuticals (US) Recent Development
11.5 Ophthotech (US)
11.5.1 Ophthotech (US) Company Details
11.5.2 Ophthotech (US) Business Overview
11.5.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.5.5 Ophthotech (US) Recent Development
11.6 GlaxoSmithKline (US)
11.6.1 GlaxoSmithKline (US) Company Details
11.6.2 GlaxoSmithKline (US) Business Overview
11.6.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.6.5 GlaxoSmithKline (US) Recent Development
11.7 Alimera Sciences (US)
11.7.1 Alimera Sciences (US) Company Details
11.7.2 Alimera Sciences (US) Business Overview
11.7.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.7.5 Alimera Sciences (US) Recent Development
11.8 StemCell (Canada)
11.8.1 StemCell (Canada) Company Details
11.8.2 StemCell (Canada) Business Overview
11.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Introduction
11.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.8.5 StemCell (Canada) Recent Development
11.9 F. Hoffmann-La Roche (Switzerland)
11.9.1 F. Hoffmann-La Roche (Switzerland) Company Details
11.9.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction
11.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.9.5 F. Hoffmann-La Roche (Switzerland) Recent Development
11.10 Regeneron Pharmaceutical (US)
11.10.1 Regeneron Pharmaceutical (US) Company Details
11.10.2 Regeneron Pharmaceutical (US) Business Overview
11.10.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
11.10.5 Regeneron Pharmaceutical (US) Recent Development
11.11 Allergan (Ireland)
10.11.1 Allergan (Ireland) Company Details
10.11.2 Allergan (Ireland) Business Overview
10.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Introduction
10.11.4 Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
10.11.5 Allergan (Ireland) Recent Development
11.12 Adverum Biotechnologies (US)
10.12.1 Adverum Biotechnologies (US) Company Details
10.12.2 Adverum Biotechnologies (US) Business Overview
10.12.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Introduction
10.12.4 Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
10.12.5 Adverum Biotechnologies (US) Recent Development
11.13 Gilead Sciences (US)
10.13.1 Gilead Sciences (US) Company Details
10.13.2 Gilead Sciences (US) Business Overview
10.13.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction
10.13.4 Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
10.13.5 Gilead Sciences (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Wet Age-Related Macular Degeneration (Wet AMD)
Table 4. Key Players of Dry Age-Related Macular Degeneration (Dry AMD)
Table 5. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2015-2020)
Table 9. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2021-2026)
Table 11. Wet Age Related Macular Degeneration (AMD) Market Market Trends
Table 12. Wet Age Related Macular Degeneration (AMD) Market Drivers
Table 13. Wet Age Related Macular Degeneration (AMD) Market Challenges
Table 14. Wet Age Related Macular Degeneration (AMD) Market Restraints
Table 15. Global Wet Age Related Macular Degeneration (AMD) Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players (2015-2020)
Table 17. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2019)
Table 18. Global Wet Age Related Macular Degeneration (AMD) by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Type (2015-2020)
Table 24. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2021-2026)
Table 25. Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Application (2015-2020)
Table 26. Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Application (2021-2026)
Table 28. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2015-2020)
Table 30. North America Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Wet Age Related Macular Degeneration (AMD) Market Share by Application (2015-2020)
Table 32. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2015-2020)
Table 34. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2015-2020)
Table 36. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Application (2015-2020)
Table 38. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Country (2015-2020)
Table 40. China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020) (US$ Million)
Table 41. China Wet Age Related Macular Degeneration (AMD) Market Share by Type (2015-2020)
Table 42. China Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020) (US$ Million)
Table 43. China Wet Age Related Macular Degeneration (AMD) Market Share by Application (2015-2020)
Table 44. China Wet Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million) (2015-2020)
Table 45. China Wet Age Related Macular Degeneration (AMD) Market Share by Region (2015-2020)
Table 46. Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Wet Age Related Macular Degeneration (AMD) Market Share by Type (2015-2020)
Table 48. Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Wet Age Related Macular Degeneration (AMD) Market Share by Application (2015-2020)
Table 50. Japan Wet Age Related Macular Degeneration (AMD) Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Wet Age Related Macular Degeneration (AMD) Market Share by Country (2015-2020)
Table 52. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Type (2015-2020)
Table 54. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Application (2015-2020)
Table 56. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Country (2015-2020)
Table 58. Novartis International (Switzerland) Company Details
Table 59. Novartis International (Switzerland) Business Overview
Table 60. Novartis International (Switzerland) Product
Table 61. Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 62. Novartis International (Switzerland) Recent Development
Table 63. Bayer (Germany) Company Details
Table 64. Bayer (Germany) Business Overview
Table 65. Bayer (Germany) Product
Table 66. Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 67. Bayer (Germany) Recent Development
Table 68. Acucela (US) Company Details
Table 69. Acucela (US) Business Overview
Table 70. Acucela (US) Product
Table 71. Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 72. Acucela (US) Recent Development
Table 73. Neurotech Pharmaceuticals (US) Company Details
Table 74. Neurotech Pharmaceuticals (US) Business Overview
Table 75. Neurotech Pharmaceuticals (US) Product
Table 76. Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 77. Neurotech Pharmaceuticals (US) Recent Development
Table 78. Ophthotech (US) Company Details
Table 79. Ophthotech (US) Business Overview
Table 80. Ophthotech (US) Product
Table 81. Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 82. Ophthotech (US) Recent Development
Table 83. GlaxoSmithKline (US) Company Details
Table 84. GlaxoSmithKline (US) Business Overview
Table 85. GlaxoSmithKline (US) Product
Table 86. GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 87. GlaxoSmithKline (US) Recent Development
Table 88. Alimera Sciences (US) Company Details
Table 89. Alimera Sciences (US) Business Overview
Table 90. Alimera Sciences (US) Product
Table 91. Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 92. Alimera Sciences (US) Recent Development
Table 93. StemCell (Canada) Business Overview
Table 94. StemCell (Canada) Product
Table 95. StemCell (Canada) Company Details
Table 96. StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 97. StemCell (Canada) Recent Development
Table 98. F. Hoffmann-La Roche (Switzerland) Company Details
Table 99. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 100. F. Hoffmann-La Roche (Switzerland) Product
Table 101. F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 102. F. Hoffmann-La Roche (Switzerland) Recent Development
Table 103. Regeneron Pharmaceutical (US) Company Details
Table 104. Regeneron Pharmaceutical (US) Business Overview
Table 105. Regeneron Pharmaceutical (US) Product
Table 106. Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 107. Regeneron Pharmaceutical (US) Recent Development
Table 108. Allergan (Ireland) Company Details
Table 109. Allergan (Ireland) Business Overview
Table 110. Allergan (Ireland) Product
Table 111. Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 112. Allergan (Ireland) Recent Development
Table 113. Adverum Biotechnologies (US) Company Details
Table 114. Adverum Biotechnologies (US) Business Overview
Table 115. Adverum Biotechnologies (US) Product
Table 116. Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 117. Adverum Biotechnologies (US) Recent Development
Table 118. Gilead Sciences (US) Company Details
Table 119. Gilead Sciences (US) Business Overview
Table 120. Gilead Sciences (US) Product
Table 121. Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2015-2020) (US$ Million)
Table 122. Gilead Sciences (US) Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Wet Age Related Macular Degeneration (AMD) Market Share by Type: 2020 VS 2026
Figure 2. Wet Age-Related Macular Degeneration (Wet AMD) Features
Figure 3. Dry Age-Related Macular Degeneration (Dry AMD) Features
Figure 4. Global Wet Age Related Macular Degeneration (AMD) Market Share by Application: 2020 VS 2026
Figure 5. Above 75 Years Case Studies
Figure 6. Above 60 Years Case Studies
Figure 7. Above 40 Years Case Studies
Figure 8. Wet Age Related Macular Degeneration (AMD) Report Years Considered
Figure 9. Global Wet Age Related Macular Degeneration (AMD) Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions: 2020 VS 2026
Figure 11. Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2021-2026)
Figure 12. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players in 2019
Figure 13. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue in 2019
Figure 15. North America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 43. Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 44. Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 45. Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 46. Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 47. GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 48. Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 49. StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 50. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 51. Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 52. Allergan (Ireland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 53. Adverum Biotechnologies (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 54. Gilead Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs